These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 9050875)

  • 1. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.
    Price DA; Goulder PJ; Klenerman P; Sewell AK; Easterbrook PJ; Troop M; Bangham CR; Phillips RE
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1890-5. PubMed ID: 9050875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
    da Silva J; Hughes AL
    Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs.
    Ueno T; Idegami Y; Motozono C; Oka S; Takiguchi M
    J Immunol; 2007 May; 178(9):5513-23. PubMed ID: 17442933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
    Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
    J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs.
    Ngandu NG; Bredell H; Gray CM; Williamson C; Seoighe C;
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1033-41. PubMed ID: 17725421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
    Karlsson AC; Iversen AK; Chapman JM; de Oliviera T; Spotts G; McMichael AJ; Davenport MP; Hecht FM; Nixon DF
    PLoS One; 2007 Feb; 2(2):e225. PubMed ID: 17311088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef.
    Goulder PJ; Edwards A; Phillips RE; McMichael AJ
    AIDS; 1997 Dec; 11(15):1883-4. PubMed ID: 9412709
    [No Abstract]   [Full Text] [Related]  

  • 15. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
    Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
    Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching and emergence of CTL epitopes in HIV-1 infection.
    Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
    Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population.
    Furutsuki T; Hosoya N; Kawana-Tachikawa A; Tomizawa M; Odawara T; Goto M; Kitamura Y; Nakamura T; Kelleher AD; Cooper DA; Iwamoto A
    J Virol; 2004 Aug; 78(16):8437-45. PubMed ID: 15280452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.